Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The Case for Nuclear Oncology Specialization: Training Physicians for Radiopharmaceutical Therapy.

Created on 12 Sep 2026

Authors

Martin Gotthardt, Hossein Jadvar, David Mankoff

Published in

Journal of nuclear medicine : official publication, Society of Nuclear Medicine. Volume 67. Issue Suppl 2. Pages 45S-50S. Sep 11, 2026. Epub Sep 11, 2026.

Abstract

Radiopharmaceutical therapy has always been an essential component of nuclear medicine practice; however, its rapid expansion in the past 5-10 y has created an increased demand for practitioners trained in this specific subspecialty, which we term nuclear oncology. This review discusses training needs for nuclear oncology or theranostics, the approach to education in theranostics, and soft skills for theranostics practice. This review is intended to guide and facilitate ongoing discussion and debate on this important topic.

PMID:
42728100
Bibliographic data and abstract were imported from PubMed on 12 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 40
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement